Canine Tick-Borne Illnesses: A Comprehensive Review of Pathogens, Symptoms, and Veterinary Management

Tick-borne diseases constitute a major infectious disease category in companion animal practice. Canine patients are exposed to a wide array of bacterial and protozoal pathogens transmitted through the feeding activity of ixodid ticks [1, 2]. The clinical presentation of these infections ranges from subclinical carrier states to severe, life-threatening systemic illness [1, 3]. This review synthesizes current knowledge on the major tick-borne pathogens of dogs, their clinical manifestations, diagnostic methods, and evidence-based therapeutic strategies, with a focus on pathogens documented in recent surveys and clinical trials [4, 3, 2].

Pathogens Transmitted by Ticks to Dogs

The order Rickettsiales contains several obligate intracellular bacteria that cause significant disease in dogs. These include species of Ehrlichia, Anaplasma, and Rickettsia [1]. Additionally, members of the order Legionellales, such as Coxiella burnetii, have been detected in canine tick populations [1]. Protozoan parasites of the genus Babesia are also frequently identified in tick-infested dogs [4, 3, 2]. A summary of primary pathogens and their tick vectors is presented in Table 1.

Table 1. Major Canine Tick-Borne Pathogens and Their Primary Tick Vectors

Clinical Signs and Pathophysiology

Clinical manifestations are highly dependent on the pathogen species and the host immune status. Ehrlichia canis infection typically progresses through three phases: acute, subclinical, and chronic [1]. The acute phase is characterized by fever, lethargy, lymphadenomegaly, and thrombocytopenia [1]. In chronic ehrlichiosis, dogs may develop pancytopenia, epistaxis, and secondary infections due to bone marrow suppression [1]. Anaplasma platys causes cyclical thrombocytopenia with mild to moderate bleeding tendencies [1]. Rickettsia rickettsii infection in dogs can produce fever, petechiation, and neurological deficits [1].

Babesiosis presents with hemolytic anemia, icterus, and fever. In a case report from Nagaland, India, a four-month-old dog infected with Babesia gibsoni exhibited progressive weight loss, reduced appetite, lethargy, icterus, enlarged lymph nodes, and bilirubinuria [3]. Hematological analysis revealed severe anemia with mild neutrophilia, and biochemical abnormalities included hyperaspartatemia, hypoalbuminemia, and hyperbilirubinemia [3]. The tick vector was morphologically identified as Rhipicephalus sanguineus [3].

Diagnostic Approaches

Definitive diagnosis of tick-borne diseases relies on a combination of microscopic examination, serological assays, and molecular techniques.

Microscopy

Examination of Giemsa-stained peripheral blood smears remains a valuable initial diagnostic tool. Intracellular inclusions (morulae) of Ehrlichia canis or Anaplasma platys may be visualized within monocytes or platelets, respectively [1, 3]. Babesia organisms appear as pear-shaped merozoites within erythrocytes [3]. However, sensitivity is limited in low-level parasitemia or bacteremia [3].

Serology

Enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence assays (IFAs) detect antibodies against specific tick-borne pathogens. These methods are useful for population surveys and for confirming exposure [1, 2]. A survey of pet dogs and cats in mainland China using serological methods revealed widespread exposure to Ehrlichia and Anaplasma species [2]. Cross-reactivity among closely related Rickettsiales can complicate interpretation [1].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting conserved genes (e.g., 16S rRNA for bacteria, 18S rRNA for Babesia) offer high sensitivity and specificity [1, 4, 3, 2]. Real-time PCR permits quantification of pathogen load. In the comparative treatment study of Babesia gibsoni, PCR was used to confirm infection and monitor therapeutic response [4].

Figure 1. Diagnostic Workflow for Suspected Canine Tick-Borne Illness

flowchart TD
    A["Canine patient with clinical signs: fever, lethargy, anemia, thrombocytopenia"] --> B{History of tick exposure?}
    B -->|Yes| C[Perform blood smear microscopy + in-clinic ELISA]
    B -->|No| D["Consider other differentials: IMHA, leptospirosis, etc."]
    C --> E{Smear positive for morulae or Babesia?}
    E -->|Yes| F["Presumptive diagnosis; confirm with PCR"]
    E -->|No| G[Perform PCR panel for Ehrlichia, Anaplasma, Babesia, Rickettsia]
    F --> H[Initiate targeted therapy based on pathogen]
    G --> I{PCR positive?}
    I -->|Yes| H
    I -->|No| J[Consider repeat PCR or serology after 2-3 weeks]
    J --> K[If still negative, evaluate for other tick-borne agents or non-infectious causes]

Veterinary Management and Treatment

Therapeutic protocols vary by pathogen. Doxycycline at 5-10 mg/kg orally every 12-24 hours for 14-28 days is the cornerstone of treatment for Ehrlichia canis, Anaplasma platys, and Rickettsia rickettsii [1]. Babesia infections require antiprotozoal agents.

A clinical trial comparing Artesunate-Atovaquone-Azithromycin (AAA) versus Doxycycline-Clindamycin-Metronidazole (DCM) regimens in dogs naturally infected with Babesia gibsoni found that the AAA combination achieved significantly faster clearance of parasitemia and improvement in hematocrit [4]. In the case report from Nagaland, treatment with Diminazene aceturate combined with Doxycycline and supportive therapy (fluid therapy, hepatoprotectants) resulted in clinical recovery [3].

For Coxiella burnetii infection, doxycycline is also recommended, although clinical disease in dogs is rarely reported [1].

Adjunctive supportive care includes fluid therapy for dehydration, blood transfusion in severe anemia, and hepatoprotective agents for icterus [4, 3].

Prevention and Control

Prevention is based on effective tick control using acaricidal products (topical spot-ons, collars, oral isoxazolines) and avoidance of tick-infested environments [1, 2]. Regular screening of blood samples from high-risk populations using PCR can help identify subclinical carriers [2]. In endemic regions, client education regarding tick removal and environmental management is critical.

Conclusion

Canine tick-borne illnesses represent a complex diagnostic challenge due to overlapping clinical signs and the possibility of co-infections [1, 2]. A systematic approach combining microscopy, serology, and PCR improves diagnostic accuracy [4, 3]. Treatment must be pathogen-specific, with doxycycline for rickettsial infections and antiprotozoal combinations for babesiosis [4, 3]. Continued surveillance of tick populations and pathogen prevalence, as demonstrated in recent surveys [2], is essential for adapting prevention strategies.

References

[1] Khamesipour F, Dida GO, Anyona DN, et al. Tick-borne zoonoses in the Order Rickettsiales and Legionellales in Iran: A systematic review. PLoS Negl Trop Dis. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30204754/

[2] Ye Q, Zhang G, Wang R, et al. Survey of tick species and tick-borne pathogens in pet dogs and cats in mainland China. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42155156/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[3] Kuotsu K, Ozukum S, Begam R, et al. Diagnosis and Therapeutic Management of Canine Babesiosis Infection in Nagaland, India- A Case Report. Indian Journal of Animal Research. 2025. URL: https://www.semanticscholar.org/paper/5e095d8659c043133e56249ae15d84dd4782af2e

[4] Pati M, Patra RC, Jena GR, et al. Comparative therapeutic efficacy of Artesunate-Atovaquone-Azithromycin and Doxycycline-Clindamycin-Metronidazole regimens in dogs naturally infected with Babesia gibsoni. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42289158/